VapeMania® Issues Recall for Certain Products
In a recent announcement, VapeMania®, a well-known brand in the cannabinoid market, advised customers regarding the disposal of specific CBN products. This situation arose after the Fukuoka Prefectural Pharmaceutical Affairs Division conducted an independent procurement investigation, revealing trace amounts of HHC (Hexahydrocannabinol) and Δ9-THC detected in several of their products. It's important to note that this detection was not due to any health complaints from consumers; rather, it stemmed from random governmental testing.
VapeMania® expressed their sincere apologies to loyal customers for the inconvenience and concern these revelations may have caused. They are urgently asking anyone in possession of the affected products to ensure their disposal.
Affected Products
The following products are included in the recall, and customers should dispose of them appropriately:
- - VapeMania® Original CBN Cartridge OG Kush
Reason for Recall: Detection of HHC (exact quantity undisclosed)
- - VapeMania® Original CBN Herb
Reason for Recall: Detection of HHC (exact quantity undisclosed)
- - VapeMania® Original CBN & CBG Gummies Night & Day (6-pouch)
Reason for Recall: Detection of Δ9-THC (exact quantity undisclosed)
Quality Control Measures
VapeMania® has emphasized its rigorous quality control measures, which include comprehensive inspections at the time of raw material importation, as well as independent testing after domestic product finalization. Only products that clear their stringent standards are released for sale. For the products identified in this recall, third-party tests confirmed compliance with safety standards regarding contents like Δ9-THC prior to sale.
Raw Materials of Affected Products
- - VapeMania® Original CBN Cartridge OG Kush
- - VapeMania® Original NIGHT & DAY Gummies Pouch
- For NIGHT
- For DAY
- - VapeMania® Original CBN Herb OG Kush
Additionally, it's worth mentioning that VapeMania® has never engaged in the development or sale of products containing the semi-synthetic cannabinoid HHC, even prior to its regulation. They maintain that the production process would theoretically make the introduction of HHC very unlikely.
Reason for Detection of Regulated Components
The information received from the Fukuoka Prefectural Pharmaceutical Affairs Division only indicated the detection of regulated substances without disclosing the quantities involved. Notably, no health issues have arisen from the use of these products, which suggests that the detected amount is likely minimal.
Past studies have documented that CBD can naturally degrade into trace amounts of THC when stored in typical room conditions, which could potentially explain the detected THC levels that exceeded safety standards post-manufacture. Additionally, the possibility of false positives from the testing cannot be ruled out. VapeMania® plans to carry out its own reinvestigation of the affected lot to better understand the situation.
Future Course of Action
VapeMania® is committed to prioritizing customer safety and comfort as they navigate these troubling intersections. They are addressing the product disposal request and ensuring responsible communication throughout. However, they also highlight that the lack of transparency regarding detected quantities complicates their ability to implement renewed preventive measures. Consequently, they intend to request the Fukuoka Prefectural Pharmaceutical Affairs Division for greater clarity on these findings, advocating for revisions to safety regulations that align with scientific realities.
Contact Information
For validation and inquiries, customers can reach out to:
Despite the challenges, VapeMania® remains dedicated to transparency and customer welfare, urging all affected customers to follow their recommendations promptly.